WHO ICTRP trial
Evaluation of the effect of nanoliposomal amphotericin B in the treatment of…
IRCT20240711062393N2 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20240711062393N2 |
|---|---|
| Public title | Evaluation of the effect of nanoliposomal amphotericin B in the treatment of patients with resistant dermatophytosis |
| Scientific title | Determining the efficacy of topical nanoliposomal amphotericin B in individuals with treatment-resistant dermatophytosis. |
| Primary sponsor | Mazandaran University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Dermatophytosis is an inflammatory skin infection caused by dermatophyte fungi including Trichophyton, Microsporum, Epidermophyton, Lophophyton, Nannizzia, Parathion, and Arthroderma.. Dermatophytosis |
| Interventions | Intervention 1: Group 1: Patients with treatment-resistant dermatophytosis (non-onychomycosis) who will receive nanoliposomal amphotericin B. Sina Ampholish 0.4% ointment is used twice a day for 4 weeks. Intervention 2: Group 2: Patients… |
| Registration date | Jun 7, 2025 |
| Target size | 75 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: